Physician profile
Andrew Yang
NPI 1649373564
$10,772.70
in general payments reported to CMS, 2019-2025
9 companies · $6,885 in 2025
The $6,885 reported for 2025 was more than what 99% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $46.98 · 2020: $433 · 2021: $17.68 · 2022: $48.88 · 2023: $269 · 2024: $3,073 · 2025: $6,885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $9,750 · Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $9,750.00 |
| Food and Beverage | $476.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $10,156.07 | 2020-2025 | Itero Element 5d Plus Lite, Mobile Configuration, Itero Element 5d Plus, Mobile Configuration, Invisalign |
| Nobel Biocare USA | $268.51 | 2023 | Nobelactive |
| Straumann USA LLC | $233.64 | 2019-2022 | |
| Solventum Corporation | $37.56 | 2024 | 3m Scotchbond, 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Geistlich Pharma, North America, INC. | $17.50 | 2025 | Biomaterials |
| Becton, Dickinson and Company | $17.21 | 2024 | Lutonix Drug Coated Balloon |
| 3m Company | $15.55 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $14.37 | 2020 | |
| Biolase, INC. | $12.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.